Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Newark, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Protagonist Therapeutics, Inc has filed 682 SEC EDGAR filings since 28 Sep 2006

SEC filing history

Showing 551-575 of 681 matching filings.

Per page
25
Current page
23
4

FORM 4 SUBMISSION

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37852

8-K

Filing date
27 Feb 2018
Reporting date
21 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

SC 13G/A

Filing date
21 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

SC 13G/A filing

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

AMENDMENT NO. 1

Filing date
07 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2018
Reporting date
16 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37852

8-K

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PROTAGONIST THERAPEUTICS, INC.

Filing date
04 Jan 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

ADAGE CAPITAL PARTNERS GP, L.L.C.

Filing date
04 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Dec 2017
Reporting date
22 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Dec 2017
Reporting date
21 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2017
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Dec 2017
Reporting date
15 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
19 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37852

8-K

Filing date
14 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Dec 2017
Reporting date
30 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Nov 2017
Reporting date
13 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37852

8-K

Filing date
06 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37852

8-K

Filing date
13 Oct 2017
Reporting date
11 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .